Year : 2022  |  Volume : 15  |  Issue : 1  |  Page : 61--63

Ivabradine monotherapy in congenital junctional ectopic tachycardia


Sivalingam Devaprasath1, Siddartha Buddhavarapu2, Suja Mariam2, Mani Ram Krishna3 
1 Department of Pediatric Cardiology, Sri Ramakrishna Hospital, Coimbatore, Tamil Nadu, India
2 Department of Neonatology, Sri Ramakrishna Hospital, Coimbatore, Tamil Nadu, India
3 Department of Pediatric Cardiology, Amrita Institute of Medical Sciences, Kochi, Kerala, India

Correspondence Address:
Dr. Mani Ram Krishna
Department of Pediatric Cardiology, Amrita Institute of Medical Sciences, Amrita Institute of Medical Sciences, Ponekkara (PO), Kochi - 682 041, Kerala
India

Congenital JET (junctional ectopic tachycardia) is a rare and often difficult to treat tachyarrhythmia in young infants. The addition of Ivabradine to standard Congenital JET therapy has been shown to improve arrhythmia control. However, Ivabradine has not been reported as a single drug in the control of congenital JET. We report a pre-term neonate in whom Ivabradine monotherapy was successful in treating congenital JET.


How to cite this article:
Devaprasath S, Buddhavarapu S, Mariam S, Krishna MR. Ivabradine monotherapy in congenital junctional ectopic tachycardia.Ann Pediatr Card 2022;15:61-63


How to cite this URL:
Devaprasath S, Buddhavarapu S, Mariam S, Krishna MR. Ivabradine monotherapy in congenital junctional ectopic tachycardia. Ann Pediatr Card [serial online] 2022 [cited 2022 Aug 16 ];15:61-63
Available from: https://www.annalspc.com/article.asp?issn=0974-2069;year=2022;volume=15;issue=1;spage=61;epage=63;aulast=Devaprasath;type=0